Medical and Pharmaceutical New drug could open personalized treatment strategies for prostate cancer Screening men for BCL2 could allow for the development of personalized treatment plans Joseph MortonSeptember 17, 2024
Medical and Pharmaceutical New Brunswick to use blood testing method for identifying lung cancer This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease Rowan DunneSeptember 16, 2024
Medical and Pharmaceutical Prelude Therapeutics Incorporated shares drop 30% on clinical trial news The drug in question is also presently being tested in an ongoing dose-escalation Phase 1 trial for patients with solid tumours Joseph MortonSeptember 13, 2024
Medical and Pharmaceutical AstraZeneca shares slide on disappointing lung cancer drug trial results "Dato-DXd" was thought to have immense potential but now appears to be a disappointment Rowan DunneSeptember 10, 2024
Health & Wellness Relay Therapeutics shares soar on positive results for breast cancer treatment Several analysts upgraded their price targets for Relay Therapeutics based on the release Joseph MortonSeptember 9, 2024
Medical and Pharmaceutical United Kingdom’s NHS stresses need for higher cancer screening rates Every year five million people who should get checked out do not, the health service says Rowan DunneSeptember 3, 2024
Medical and Pharmaceutical Lung cancer diagnostics clinic opens up at Ontario hospital Oakville Trafalgar Memorial Hospital's Lung Diagnostic Assessment Program offers 4 diagnostic procedures Rowan DunneAugust 29, 2024
Medical and Pharmaceutical American cancer screening: a US$43 billion dollar business That number comes from a study published this month in the journal 'Annals of Internal Medicine' Rowan DunneAugust 28, 2024
Medical and Pharmaceutical Johnson & Johnson may bankrupt a subsidiary to pay USD$6.9B talcum cancer settlements J&J plans to place a subsidiary into bankruptcy if at least 75 per cent of the talc claimants vote for its settlement proposal Joseph MortonAugust 28, 2024
Medical and Pharmaceutical University of Notre Dame develops novel blood testing method for brain cancer Although considered incurable, they hope early detection of glioblastoma may increase a person's survival chances Rowan DunneAugust 27, 2024